OBJECTIVES: The association between periodontal disease and adverse pregnancy outcomes (APO), primarily preterm birth (PTB), is still controversially discussed in the literature. Therefore, the aim of the present systematic review was to analyze the existing literature on the potential association between inflammatory mediators detected in gingival crevicular fluid (GCF) and APO. MATERIALS AND METHODS: MEDLINE (PubMed) and EMBASE databases were searched for entries up to April 2012 and studies were selected by two independent reviewers. RESULTS: The majority of the eight studies included confirmed a positive association between GCF mediators, such as interleukin-1β, prostaglandin E2, and tumor necrosis factor-alpha, and APO. Due to the heterogeneity and variability of the available studies, no meta-analysis could be performed. CONCLUSIONS: A positive association between GCF inflammatory mediator levels and APO/PTB might be present but the results need to be considered with great caution because of the heterogeneity and variability among the studies. Further studies with an adequate number of patients allowing for an appropriate analysis are warranted to definitely confirm this association. CLINICAL RELEVANCE: The present findings suggest that an association between GCF inflammatory mediator levels and APO might exist.
OBJECTIVES: The association between periodontal disease and adverse pregnancy outcomes (APO), primarily preterm birth (PTB), is still controversially discussed in the literature. Therefore, the aim of the present systematic review was to analyze the existing literature on the potential association between inflammatory mediators detected in gingival crevicular fluid (GCF) and APO. MATERIALS AND METHODS: MEDLINE (PubMed) and EMBASE databases were searched for entries up to April 2012 and studies were selected by two independent reviewers. RESULTS: The majority of the eight studies included confirmed a positive association between GCF mediators, such as interleukin-1β, prostaglandin E2, and tumor necrosis factor-alpha, and APO. Due to the heterogeneity and variability of the available studies, no meta-analysis could be performed. CONCLUSIONS: A positive association between GCF inflammatory mediator levels and APO/PTB might be present but the results need to be considered with great caution because of the heterogeneity and variability among the studies. Further studies with an adequate number of patients allowing for an appropriate analysis are warranted to definitely confirm this association. CLINICAL RELEVANCE: The present findings suggest that an association between GCF inflammatory mediator levels and APO might exist.
Authors: Steven Offenbacher; Dongming Lin; Robert Strauss; Rosemary McKaig; Joanna Irving; Silvana P Barros; Kevin Moss; David A Barrow; A Hefti; James D Beck Journal: J Periodontol Date: 2006-12 Impact factor: 6.993
Authors: R Romero; P Baumann; R Gomez; C Salafia; L Rittenhouse; D Barberio; E Behnke; D B Cotton; M D Mitchell Journal: Am J Obstet Gynecol Date: 1993-06 Impact factor: 8.661
Authors: Pascale F M Stadelmann; Sigrun Eick; Giovanni E Salvi; Daniel Surbek; Stefan Mohr; Walter Bürgin; Christoph A Ramseier; Anton Sculean Journal: Clin Oral Investig Date: 2014-11-26 Impact factor: 3.573
Authors: Francisco Mesa; Elena Pozo; Francisco O'Valle; Alberto Puertas; Antonio Magan-Fernandez; Eva Rosel; Manuel Bravo Journal: Clin Oral Investig Date: 2015-08-07 Impact factor: 3.573
Authors: Anna Starzyńska; Piotr Wychowański; Maciej Nowak; Bartosz Kamil Sobocki; Barbara Alicja Jereczek-Fossa; Monika Słupecka-Ziemilska Journal: Int J Mol Sci Date: 2022-02-24 Impact factor: 5.923
Authors: Stefan Mohr; Sofia K Amylidi-Mohr; Pascale Stadelmann; Anton Sculean; Rutger Persson; Sigrun Eick; Daniel V Surbek Journal: Front Immunol Date: 2019-11-07 Impact factor: 7.561